PT Pyridam Farma Tbk (PYFA.JK)
IDR 212.0
(0.95%)
IDR 212.0
(0.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -85.22 Billion IDR | -130.96% |
| 2022 | 275.24 Billion IDR | 4923.62% |
| 2021 | 5.47 Billion IDR | -75.21% |
| 2020 | 22.1 Billion IDR | 136.59% |
| 2019 | 9.34 Billion IDR | 10.6% |
| 2018 | 8.44 Billion IDR | 18.52% |
| 2017 | 7.12 Billion IDR | 38.5% |
| 2016 | 5.14 Billion IDR | 66.7% |
| 2015 | 3.08 Billion IDR | 16.01% |
| 2014 | 2.66 Billion IDR | -57.05% |
| 2013 | 6.19 Billion IDR | 16.72% |
| 2012 | 5.3 Billion IDR | 2.63% |
| 2011 | 5.17 Billion IDR | 23.17% |
| 2010 | 4.19 Billion IDR | 11.3% |
| 2009 | 3.77 Billion IDR | 63.41% |
| 2008 | 2.3 Billion IDR | 32.43% |
| 2007 | 1.74 Billion IDR | 0.81% |
| 2006 | 1.72 Billion IDR | 30.18% |
| 2005 | 1.32 Billion IDR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -69.87 Billion IDR | -54.2% |
| 2024 Q3 | -99.03 Billion IDR | -41.73% |
| 2024 Q1 | -45.31 Billion IDR | -14.08% |
| 2023 Q4 | -39.72 Billion IDR | -350.88% |
| 2023 Q2 | -24.37 Billion IDR | -97.81% |
| 2023 Q3 | -8.81 Billion IDR | 63.85% |
| 2023 Q1 | -12.32 Billion IDR | 8.94% |
| 2023 FY | -85.22 Billion IDR | -130.96% |
| 2022 Q2 | 6.55 Billion IDR | 162.65% |
| 2022 Q4 | -13.53 Billion IDR | -104.84% |
| 2022 FY | 275.24 Billion IDR | 4923.62% |
| 2022 Q1 | 2.49 Billion IDR | 123.8% |
| 2022 Q3 | 279.7 Billion IDR | 4166.62% |
| 2021 Q4 | -10.48 Billion IDR | -328.01% |
| 2021 Q2 | 513.48 Million IDR | -95.27% |
| 2021 Q1 | 10.85 Billion IDR | 81.37% |
| 2021 Q3 | 4.59 Billion IDR | 795.56% |
| 2021 FY | 5.47 Billion IDR | -75.21% |
| 2020 Q2 | 1.33 Billion IDR | -69.53% |
| 2020 FY | 22.1 Billion IDR | 136.59% |
| 2020 Q4 | 5.98 Billion IDR | -42.6% |
| 2020 Q3 | 10.42 Billion IDR | 683.41% |
| 2020 Q1 | 4.36 Billion IDR | -1.16% |
| 2019 Q1 | 1.88 Billion IDR | -54.51% |
| 2019 FY | 9.34 Billion IDR | 10.6% |
| 2019 Q4 | 4.41 Billion IDR | 39.81% |
| 2019 Q3 | 3.15 Billion IDR | 2716.14% |
| 2019 Q2 | -120.78 Million IDR | -106.4% |
| 2018 FY | 8.44 Billion IDR | 18.52% |
| 2018 Q4 | 4.14 Billion IDR | 59.75% |
| 2018 Q3 | 2.59 Billion IDR | 3591.01% |
| 2018 Q2 | 70.3 Million IDR | -95.7% |
| 2018 Q1 | 1.63 Billion IDR | -18.21% |
| 2017 Q2 | -80.49 Million IDR | -106.14% |
| 2017 Q1 | 1.31 Billion IDR | -43.12% |
| 2017 Q3 | 3.89 Billion IDR | 4939.55% |
| 2017 FY | 7.12 Billion IDR | 38.5% |
| 2017 Q4 | 2 Billion IDR | -48.63% |
| 2016 Q3 | 193.66 Million IDR | -88.6% |
| 2016 Q4 | 2.3 Billion IDR | 1090.2% |
| 2016 FY | 5.14 Billion IDR | 66.7% |
| 2016 Q2 | 1.69 Billion IDR | 78.84% |
| 2016 Q1 | 949.54 Million IDR | -59.91% |
| 2015 Q4 | 2.36 Billion IDR | 474.2% |
| 2015 FY | 3.08 Billion IDR | 16.01% |
| 2015 Q2 | 223.59 Million IDR | -80.17% |
| 2015 Q1 | 1.12 Billion IDR | -49.54% |
| 2015 Q3 | -633.02 Million IDR | -383.11% |
| 2014 FY | 2.66 Billion IDR | -57.05% |
| 2014 Q1 | 1.67 Billion IDR | -57.09% |
| 2014 Q2 | -1.15 Billion IDR | -169.12% |
| 2014 Q4 | 2.23 Billion IDR | 2534.34% |
| 2014 Q3 | -91.8 Million IDR | 92.08% |
| 2013 Q4 | 3.9 Billion IDR | 440.49% |
| 2013 Q2 | 14.44 Million IDR | -99.07% |
| 2013 Q1 | 1.54 Billion IDR | 17.19% |
| 2013 FY | 6.19 Billion IDR | 16.72% |
| 2013 Q3 | 723.11 Million IDR | 4904.92% |
| 2012 Q1 | 2.75 Billion IDR | 43658.07% |
| 2012 FY | 5.3 Billion IDR | 2.63% |
| 2012 Q3 | 577.16 Million IDR | -11.9% |
| 2012 Q4 | 1.32 Billion IDR | 129.14% |
| 2012 Q2 | 655.09 Million IDR | -76.21% |
| 2011 Q2 | 1.33 Billion IDR | -71.12% |
| 2011 Q4 | -6.32 Million IDR | 99.21% |
| 2011 Q1 | 4.63 Billion IDR | 0.0% |
| 2011 Q3 | -795.43 Million IDR | -159.42% |
| 2011 FY | 5.17 Billion IDR | 23.17% |
| 2010 FY | 4.19 Billion IDR | 11.3% |
| 2009 FY | 3.77 Billion IDR | 63.41% |
| 2008 FY | 2.3 Billion IDR | 32.43% |
| 2007 FY | 1.74 Billion IDR | 0.81% |
| 2006 FY | 1.72 Billion IDR | 30.18% |
| 2005 FY | 1.32 Billion IDR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 146.33 Billion IDR | 158.236% |
| PT Merck Tbk | 178.24 Billion IDR | 147.812% |
| PT Phapros, Tbk | 5.95 Billion IDR | 1530.043% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 950.64 Billion IDR | 108.965% |
| PT Tempo Scan Pacific Tbk | 1177.43 Billion IDR | 107.238% |